| Mr James Gallagher Underwood, CRNA | |
|
2000 Palmyra Rd, Albany, GA 31701-1528 | |
| (229) 434-2000 | |
| Not Available |
| Full Name | Mr James Gallagher Underwood |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 20 Years |
| Location | 2000 Palmyra Rd, Albany, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902910565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 145010 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phoebe Putney Memorial Hospital | Albany, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoebe Physician Group Inc | 8426112350 | 342 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Sweet Dreams Nurse Anesthesia, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649463365 PECOS PAC ID: 5294823266 Enrollment ID: O20071109000111 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Synergy Anesthesiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003040502 PECOS PAC ID: 4385781954 Enrollment ID: O20091030000317 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Nmda Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306123336 PECOS PAC ID: 7113193541 Enrollment ID: O20120105000663 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Sweet Dreams Nurse Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891005989 PECOS PAC ID: 1658568621 Enrollment ID: O20120525000211 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Sweet Dreams Anesthesiology Nurses Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669737409 PECOS PAC ID: 0941456446 Enrollment ID: O20120816000621 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Sweet Dreams Nurse Anesthesia Of Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003168923 PECOS PAC ID: 7719138353 Enrollment ID: O20121108000271 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Grand Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689230724 PECOS PAC ID: 0345579876 Enrollment ID: O20190910000358 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Prominence Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376180083 PECOS PAC ID: 5890121719 Enrollment ID: O20200219000722 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Entity Name | Radiance Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194381236 PECOS PAC ID: 5890116032 Enrollment ID: O20200526003208 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Gallagher Underwood, CRNA 2000 Palmyra Rd, Albany, GA 31701-1528 Ph: (229) 434-2000 | Mr James Gallagher Underwood, CRNA 2000 Palmyra Rd, Albany, GA 31701-1528 Ph: (229) 434-2000 |
News Archive
Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.
ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
A single dose of the antibiotic ceftriaxone given for antimicrobial prophylaxis prior to surgery enhanced patient pain thresholds after the procedure, according to a study published in The Journal of Pain, the peer review publication of the American Pain Society.
A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.
› Verified 4 days ago
Kirby Kitchens, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2311 W Doublegate Dr, Albany, GA 31721 Phone: 229-888-2554 Fax: 229-888-2554 | |
Randall J Cannady, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-5800 Fax: 229-312-5853 | |
Misty Grimes, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000 | |
Terrance L Cannon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-439-9400 Fax: 229-436-3718 | |
Robert H Nelson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000 Fax: 312-312-1215 | |
Mrs. Lisa D Vallely, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2000 Palmyra Rd, Albany, GA 31701 Phone: 229-434-2161 Fax: 229-434-2502 | |
Terry Joe Durham, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 531 7th Ave, Albany, GA 31701 Phone: 229-438-9922 Fax: 229-438-9922 |